1st Quarter - Amendment

BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$67,350
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report May 18, 2012 $23,000 Replaced
1st Quarter - Amendment (this page) Oct 18, 2012 $67,350 Replaced
1st Quarter - Amendment Aug 6, 2013 $67,350 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

The Prescription Drug User Fee Act

LobbyistCovered position, as disclosed
GEORGE DAHLMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Fundin for blood cancer education program and blood cancer research through the Labor, Health and Human Services, and Education appropriations bill, and the DoD appropriations bill for FY 2013

LobbyistCovered position, as disclosed
GEORGE DAHLMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.